Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. We have a comprehensive product portfolio and pipeline that addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a variety of major spinal disorders and surgical procedures. Our principal product offerings are focused on the global market for orthopedic spinal disorder solutions. Our “surgeons’ culture” enables us to respond to changing surgeon needs through collaboration with spinal surgeons to conceptualize, design and co-develop a broad range of products. We have a state-of-the-art, in-house manufacturing facility that provides us with a unique competitive advantage, and enables us to rapidly deliver solutions to meet surgeons’ and patients’ critical needs. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.01 |
| Quarterly EPS Est: | -0.01 |
| PEG Ratio: | -.05 |
|
Mean Recommendation: View Summary / View All |
1.8 |
Data is provided by Zacks Investment Research
